Literature DB >> 8061722

Insulin secretion, clearance and action before and after gastroplasty in severely obese subjects.

M R Letiexhe1, A J Scheen, P L Gérard, C Desaive, P J Lefèbvre.   

Abstract

This study investigated the effects of a drastic weight reduction on insulin secretion rate (ISR), insulin metabolic clearance rate (MCRI) and insulin sensitivity (SI) in severely obese subjects. A frequently sampled intravenous glucose tolerance test (FSIVGTT, 0.3 g/kg) was performed before and 8 +/- 1 months after a vertical ring gastroplasty in 12 overnight-fasted obese non-diabetic subjects; the results were compared to those obtained in 12 lean controls matched for age and sex. ISR was derived by deconvolution of plasma C-peptide levels; MCRI was obtained by dividing the area under the curve (AUC180 min) of ISR by the corresponding AUC of plasma insulin levels (IRI); the SI and the glucose effectiveness index (SG) were calculated by Bergman's minimal model. Before gastroplasty, obese subjects showed significantly higher ISR (P < 0.02), lower MCRI (P < 0.001), lower SI (P < 0.001) but similar SG when compared to lean controls. After gastroplasty (reduction of body weight from 104.8 +/- 3.8 to 73.4 +/- 3.6 kg and of BMI from 37.9 +/- 0.8 to 26.5 +/- 0.9 kg/m2; P < 0.001), ISR only decreased from 53,125 +/- 7968 to 42,302 +/- 3716 pmol/180 min (not significant) while AUC-IRI dramatically fell from 53,626 +/- 6378 to 21,111 +/- 2584 pmol.min/l; P < 0.001); consequently, MCRI markedly increased from 526 +/- 96 to 1257 +/- 150 ml/min/m2; P < 0.01). SI significantly rose from 3.12 +/- 0.45 to 7.10 +/- 1.20 x 10(-4) l/mU/min (P < 0.005) while SG remained unchanged.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8061722

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  9 in total

1.  Effects of sleeve gastrectomy and medical treatment for obesity on glucagon-like peptide 1 levels and glucose homeostasis in non-diabetic subjects.

Authors:  Juan Patricio Valderas; Veronica Irribarra; Lorena Rubio; Camilo Boza; Manuel Escalona; Yessica Liberona; Andrea Matamala; Alberto Maiz
Journal:  Obes Surg       Date:  2011-07       Impact factor: 4.129

2.  Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test.

Authors:  Michael Staup; George Aoyagi; TeQuana Bayless; Yixin Wang; Keefe Chng
Journal:  J Vis Exp       Date:  2016-11-13       Impact factor: 1.355

3.  Weight loss therapy improves pancreatic endocrine function in obese older adults.

Authors:  Dennis T Villareal; Marian R Banks; Bruce W Patterson; Kenneth S Polonsky; Samuel Klein
Journal:  Obesity (Silver Spring)       Date:  2008-04-03       Impact factor: 5.002

4.  Plasma leptin levels, insulin secretion, clearance and action on glucose metabolism in anorexia nervosa.

Authors:  M R Letiexhe; A J Scheen; P J Lefèbvre
Journal:  Eat Weight Disord       Date:  1997-06       Impact factor: 4.652

Review 5.  Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence?

Authors:  Mousumi Bose; Blanca Oliván; Julio Teixeira; F Xavier Pi-Sunyer; Blandine Laferrère
Journal:  Obes Surg       Date:  2008-09-27       Impact factor: 4.129

Review 6.  Effects of bariatric surgery on glucose homeostasis and type 2 diabetes.

Authors:  David Bradley; Faidon Magkos; Samuel Klein
Journal:  Gastroenterology       Date:  2012-08-08       Impact factor: 22.682

7.  Quantification of β-cell insulin secretory function using a graded glucose infusion with C-peptide deconvolution in dysmetabolic, and diabetic cynomolgus monkeys.

Authors:  Xiaoli Wang; Barbara C Hansen; Da Shi; Yupeng Fang; Fenglai Du; Bingdi Wang; Yaxiong Michael Chen; Francine M Gregoire; Yi-Xin Jim Wang
Journal:  Diabetol Metab Syndr       Date:  2013-07-25       Impact factor: 3.320

8.  Effect of Medical and Surgical Interventions on α-Cell Function in Dysglycemic Youth and Adults in the RISE Study.

Authors:  Steven E Kahn; Sharon L Edelstein; Silva A Arslanian; Elena Barengolts; Sonia Caprio; David A Ehrmann; Tamara S Hannon; Santica Marcovina; Kieren J Mather; Kristen J Nadeau; Kristina M Utzschneider; Anny H Xiang; Thomas A Buchanan
Journal:  Diabetes Care       Date:  2021-06-16       Impact factor: 17.152

9.  Obesity: prevalence, theories, medical consequences, management, and research directions.

Authors:  Colin Wilborn; Jacqueline Beckham; Bill Campbell; Travis Harvey; Melyn Galbreath; Paul La Bounty; Erika Nassar; Jennifer Wismann; Richard Kreider
Journal:  J Int Soc Sports Nutr       Date:  2005-12-09       Impact factor: 5.150

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.